US$ 26.95
glp 1 gip dual agonist mechanism of action Main physiological actions the and GLP-1 Frontiers | GLP−1 receptor agonists
Description
Incretin-based therapies and diabetic retinopathy: real-world evidence in Older U.S

How Foundayo Weight Loss Results Compare With the Wegovy Pill By the end of the study, people on the highest dose lost an average of about 27 pounds (12.4 percent of their starting body weight), compared with average weight loss of just 2.2 pounds with the placebo

Semaglutide (Wegovy/Ozempic) is the closest currently available alternative, producing 14-16% average weight loss compared to tirzepatide at 18-22%
doi: 10.1111/bjd.12886 42 MoensEVeldhoenM
doi: 10.1210/clinem/dgaa863 [DOI] [PMC free article] [PubMed] [Google Scholar] 25.Samms RJ, Coghlan MP, Sloop KW

Then restart at a lower dose and titrate back up
